Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1995
DOI: 10.1016/0360-3016(95)00157-t
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of tumor regression during radiotherapy for head and neck cancer: A prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
32
1

Year Published

1996
1996
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(37 citation statements)
references
References 14 publications
1
32
1
Order By: Relevance
“…Although no correlation with LRC was found, the ΔV 2 weeks with a threshold of 20% showed high NPV. Jaulerry et al showed that tumour regression of 25% at 2 weeks during RT was predictive of CR after RT [7]. However, in the current study, a high number of responding primary tumoral and nodal metastatic lesions showed no substantial volume regression during CRT.…”
Section: Discussioncontrasting
confidence: 79%
“…Although no correlation with LRC was found, the ΔV 2 weeks with a threshold of 20% showed high NPV. Jaulerry et al showed that tumour regression of 25% at 2 weeks during RT was predictive of CR after RT [7]. However, in the current study, a high number of responding primary tumoral and nodal metastatic lesions showed no substantial volume regression during CRT.…”
Section: Discussioncontrasting
confidence: 79%
“…Volumetric analysis during chemotherapy and radiotherapy (RT) has shown variable results [6][7][8]. Although the metabolic response on 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) during CRT reflects the tumour response to CRT, it is also modified by treatmentinduced inflammation [9,10].…”
Section: Introductionmentioning
confidence: 99%
“…The main result has been better control of primary tumours, whereas the cure rate of patients with nodal involvement has not improved significantly. Nodal involvement is still a strong, independent, prognostic indicator (5,(9)(10)(11)(12). The present paper focuses on the tumour burden of lymph node metastases as an independent prognostic factor.…”
Section: Original Articlementioning
confidence: 99%